Back to STATE STREET CORP STATE STREET CORP

KYTXKYTX
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in KYVERNA THERAPEUTICS INC

STATE STREET CORP holds 982,233 shares of KYTX (KYVERNA THERAPEUTICS INC), worth $8.8M as of 2026-Q2. The position was increased (+610.2% shares). KYTX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$8.8M

Current Shares

982,233

Total Value Change

+$7.2M

Total Shares Change

+656,041

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
982,233
+610.2%
$8.8M0.0%$8.91
44
2026-Q1
Increased
138,300
+51.5%
$1.2M0.0%$8.02
24
2025-Q4
Unchanged
91,300
0.0%
$858,2200.0%$9.35
0
2025-Q3
Unchanged
91,300
0.0%
$547,8000.0%$5.94
0
2025-Q2
Decreased
91,300
-75.6%
$280,2910.0%$3.28
0
2025-Q1
Decreased
374,578
-1.4%
$722,9360.0%$2.00
0
2024-Q4
Increased
379,888
+16.5%
$1.4M0.0%$3.64
30
2024-Q3
Increased
326,192
+3.2%
$1.6M0.0%$5.23
26

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used